Le Lézard
Classified in: Science and technology, Business
Subject: TNM

Cisco Completes Acquisition of Isovalent to Define the Future of Multicloud Networking and Security


News Summary:

SAN JOSE, Calif., April 12, 2024 /PRNewswire/ -- Cisco (NASDAQ: CSCO) today announced the completion of the acquisition of Isovalent, a leader in open source cloud native networking and security. This marks a significant step forward in Cisco's commitment to define the future of secure, multicloud networking.

Isovalent's innovative technologies will become a cornerstone of the Cisco Security Cloud vision, an AI-driven, cloud-delivered, integrated security platform designed to accommodate organizations of any size, offering cutting-edge protection against threats in a multicloud world.

Isovalent's team has been a major contributor to the open source technology eBPF and has led the development of cloud-native solutions Cilium and Tetragon. These advancements provide IT and platform engineering with robust networking capabilities and enhanced visibility into cloud native interactions, enabling smooth policy definition and enforcement across software defined networks.

The Isovalent team joins the Cisco Security Business Group.

Additional Resources

About Cisco 

Cisco (NASDAQ: CSCO) is the worldwide technology leader that securely connects everything to make anything possible. Our purpose is to power an inclusive future for all by helping our customers reimagine their applications, power hybrid work, secure their enterprise, transform their infrastructure, and meet their sustainability goals. Discover more on The Newsroom and follow us on X at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company.

Cisco Forward-Looking Statements 

This press release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," "strives," "goal," "intends," "may," "endeavors," "continues," "projects," "seeks," or "targets," or the negative of these terms or other comparable terminology, as well as similar expressions, or regarding the acquisition building leading edge protection, the expected benefits to Cisco and its customers from completing the acquisition, and plans regarding Isovalent, Inc. personnel. Readers should not place undue reliance on these forward-looking statements, as these statements are management's beliefs and assumptions, many of which, by their nature, are inherently uncertain, and outside of management's control. Additionally, Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due a variety of factors, including, among other things,  the potential impact on the business of Isovalent, Inc. due to the uncertainty about the acquisition, the retention of employees of Isovalent, Inc. and the ability of Cisco to successfully integrate Isovalent, Inc. and to achieve expected benefits, business and economic conditions and growth trends in the networking and security industries, customer markets and various geographic regions, global economic conditions and uncertainties in the geopolitical environment and other risk factors set forth in Cisco's most recent reports on Form 10-K and Form 10-Q. Any forward-looking statements in this press release are based on limited information currently available to Cisco, which is subject to change, and Cisco will not necessarily update the information.

SOURCE Cisco Systems, Inc.


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: